Crossmark

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1186/s12885-016-2694-2

Published Online: 2016-08-20

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Davis, Elizabeth J.

Zhao, Lili

Lucas, David R.

Schuetze, Scott M.

Baker, Laurence H.

Zalupski, Mark M.

Thomas, Dafydd

Chugh, Rashmi
Funding

Funding for this research was provided by:

Eli Lilly and Company

Sanofi
License Information

License valid from 2016-08-20